25th Annual National Marfan Foundation Conference

描述(由申请人提供)： 第25届马凡综合征及相关疾病年会将于2009年8月6日至9日在明尼苏达州罗切斯特的梅奥诊所与国家马凡基金会(NMF)合作举行。这次会议是一个为期四天的完全整合的活动，其中包括针对马凡氏综合症患者及其家人的70多个研讨会、支持小组和教育计划；针对医疗专业人员的继续医学教育计划；针对儿童和青少年的同步计划；以及全国领先的马凡氏综合症专家NMF专业咨询委员会(PAB)的正式会议，讨论研究、治疗和诊断标准的最新进展。此外，梅奥诊所将举办一次免费诊所，与会者将接受PAB成员、梅奥专家和特邀客座医生的现场医学测试和评估。梅奥诊所是贝塔阻滞剂疗法(阿替洛尔)与血管紧张素II受体阻滞剂疗法(氯沙坦)在马凡综合征患者中试验的注册网站。有关试验的信息将在会议上向消费者和医疗专业人员提供。由美国国立卫生研究院赞助的国家遗传触发主动脉瘤和心血管疾病登记处(GenTAC)也将现场登记合格的参与者，以收集因基因改变而导致的动脉瘤和夹层患者的临床数据和样本。(摘要结束)

DESCRIPTION (provided by applicant): The 25th Annual Conference on Marfan Syndrome and Related Disorders will take place August 6-9, 2009 at Mayo Clinic in Rochester Minnesota in collaboration with the National Marfan Foundation (NMF). The conference is a fully-integrated four-day event that includes more than 70 workshops, support groups and educational programs for people affected with Marfan syndrome and related disorders and their families; a CME program for medical professionals; concurrent programs for children and teens; and a formal meeting of the NMF Professional Advisory Board (PAB), the nation's leading specialists in the disorder, to discuss the latest advancements in research, treatment, and diagnostic criteria. In addition, Mayo Clinic will host a free clinic where conference participants will receive on-site medical testing and assessment by PAB members, Mayo specialists and invited guest physicians. Mayo Clinic is an enrollment site for the trial of Beta Blocker Therapy (atenolol) vs. Angiotensin II Receptor Blocker Therapy (losartan) in Individuals with Marfan Syndrome. Information on the trial will be available at the conference for consumers and medical professionals. The NIH-sponsored National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) will also be on-site to enroll eligible participants in a registry to collect clinical data and samples on patients with aneurysms and dissections that are caused by genetic alterations. (End of Abstract)